The approval of CDK4/6 inhibitors has dramatically improved care for the treatment of
HR+/HER2–advanced breast cancer, but navigating the rapidly-expanding treatment …

Medication adherence is directly associated with health outcomes. Adherence has been
reviewed extensively; however, most studies provide a narrow scope of the problem …

This article explores the transformative impact of Artificial Intelligence (AI) in oncology
pharmacy. Oncology pharmacists, traditionally pivotal to cancer management, are now …

Objective We aimed to develop of a risk stratification model for the pharmaceutical care of
patients with solid or hematologic neoplasms who required antineoplastic agents or …

Purpose Patient reported outcome measures (PROMs) are increasingly used in oncology
care, but pharmacists providing direct patient care have been overlooked. We engaged …

PURPOSE There is a lack of systematic solutions to manage supportive care issues in
racial/ethnic minorities (REM) receiving treatment for cancer. We developed and …

Objective The objective of this review is to provide an overview of common drug-drug
interactions (DDIs) associated with prostate cancer treatments and outline recommendations …

Introduction Nigeria is a low-middle income country located in sub-Saharan Africa. Although
cancer burden has continued to increase over time, there is a lack of pharmacists who …

Introduction Pharmacists are needed as members of oncology teams. The Japanese Society
of Hospital Pharmacists (JSHP) conducts a nationwide survey annually to analyze the actual …

Purpose To describe the application of the Plan-Do-Study-Act quality improvement
framework in the development, implementation, and evaluation of a novel pharmacy practice …